Tapewire

Nasdaq · USD

INSM

INSMED Inc

Export transactions ↓
Tapewire entity
3174
SEC CIK
0001104506
Parsed reports
490

Last 12 months

Inside the activity.

0 purchase rows · 169 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025023
Dec 2025018
Jan 2026044
Feb 2026022
Mar 202608
Apr 2026010
May 2026019
Jun 2026013
Jul 202607
Aug 202604
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 08, 2021 Filed Mar 12, 2021 21:10 UTC
Schaeffer Orlov S NicoleChief People Strategy Officer
Exercise / conversionCommon Stock 4,709 $20.49 $96,487.41
Disclosure

SEC source: 0001140361-21-008313 · form4.xml · nonDerivative · entry 1

Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,629

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 04, 2021 Filed Mar 8, 2021 21:09 UTC PurchaseCommon Stock 2,710 $36.90 $99,999.00
Disclosure

SEC source: 0001140361-21-007636 · form4.xml · nonDerivative · entry 1

ENGELSEN STEINAR J · CIK 0001218860 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 299,009

Read SEC document
February 09, 2021 Filed Feb 10, 2021 21:09 UTC
Pellizzari Christine AChief Legal Officer
Exercise / conversionStock Option (right to buy) · Derivative 15,150 $0.00 Strike: $10.85 $0.00
Disclosure

SEC source: 0001104659-21-019794 · tm213966-3_4seq1.xml · derivative · entry 6

Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,150 shares

Expires 2026-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each six-month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
February 09, 2021 Filed Feb 10, 2021 21:09 UTC
Pellizzari Christine AChief Legal Officer
SaleCommon Stock 15,150 $45.00 $681,750.00
Disclosure

SEC source: 0001104659-21-019794 · tm213966-3_4seq1.xml · nonDerivative · entry 4

Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,721

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F3 · price: This is the weighted average sales price representing 15,150 shares sold at prices ranging from $44.75 to $45.44 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
February 09, 2021 Filed Feb 10, 2021 21:09 UTC
Pellizzari Christine AChief Legal Officer
Exercise / conversionCommon Stock 15,150 $10.85 $164,377.50
Disclosure

SEC source: 0001104659-21-019794 · tm213966-3_4seq1.xml · nonDerivative · entry 3

Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 155,871

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
February 08, 2021 Filed Feb 10, 2021 21:09 UTC
Pellizzari Christine AChief Legal Officer
Exercise / conversionStock Option (right to buy) · Derivative 6,400 $0.00 Strike: $10.85 $0.00
Disclosure

SEC source: 0001104659-21-019794 · tm213966-3_4seq1.xml · derivative · entry 5

Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,150

Underlying: Common Stock · 6,400 shares

Expires 2026-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each six-month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
February 08, 2021 Filed Feb 10, 2021 21:09 UTC
Pellizzari Christine AChief Legal Officer
SaleCommon Stock 6,400 $43.95 $281,280.00
Disclosure

SEC source: 0001104659-21-019794 · tm213966-3_4seq1.xml · nonDerivative · entry 2

Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,721

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · price: This is the weighted average sales price representing 6,400 shares sold at prices ranging from $43.75 to $44.15 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
February 08, 2021 Filed Feb 10, 2021 21:09 UTC
Pellizzari Christine AChief Legal Officer
Exercise / conversionCommon Stock 6,400 $10.85 $69,440.00
Disclosure

SEC source: 0001104659-21-019794 · tm213966-3_4seq1.xml · nonDerivative · entry 1

Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 147,121

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
January 26, 2021 Filed Jan 27, 2021 21:17 UTC
Pellizzari Christine AChief Legal Officer
Exercise / conversionStock Option (right to buy) · Derivative 2,600 $0.00 Strike: $10.85 $0.00
Disclosure

SEC source: 0001104659-21-008179 · tm213966-2_4seq1.xml · derivative · entry 9

Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,550

Underlying: Common Stock · 2,600 shares

Expires 2026-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each six-month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
January 26, 2021 Filed Jan 27, 2021 21:17 UTC
Pellizzari Christine AChief Legal Officer
SaleCommon Stock 2,600 $44.04 $114,504.00
Disclosure

SEC source: 0001104659-21-008179 · tm213966-2_4seq1.xml · nonDerivative · entry 6

Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,721

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F4 · price: This is the weighted average sales price representing 2,600 shares sold at prices ranging from $43.75 to $44.23 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request

Read SEC document
January 26, 2021 Filed Jan 27, 2021 21:17 UTC
Pellizzari Christine AChief Legal Officer
Exercise / conversionCommon Stock 2,600 $10.85 $28,210.00
Disclosure

SEC source: 0001104659-21-008179 · tm213966-2_4seq1.xml · nonDerivative · entry 5

Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,321

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
January 25, 2021 Filed Jan 27, 2021 21:17 UTC
Pellizzari Christine AChief Legal Officer
Exercise / conversionStock Option (right to buy) · Derivative 6,000 $0.00 Strike: $10.85 $0.00
Disclosure

SEC source: 0001104659-21-008179 · tm213966-2_4seq1.xml · derivative · entry 8

Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,150

Underlying: Common Stock · 6,000 shares

Expires 2026-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each six-month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
January 25, 2021 Filed Jan 27, 2021 21:17 UTC
Pellizzari Christine AChief Legal Officer
Exercise / conversionStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $10.85 $0.00
Disclosure

SEC source: 0001104659-21-008179 · tm213966-2_4seq1.xml · derivative · entry 7

Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,150

Underlying: Common Stock · 15,000 shares

Expires 2026-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each six-month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
January 25, 2021 Filed Jan 27, 2021 21:17 UTC
Pellizzari Christine AChief Legal Officer
SaleCommon Stock 6,000 $43.84 $263,040.00
Disclosure

SEC source: 0001104659-21-008179 · tm213966-2_4seq1.xml · nonDerivative · entry 4

Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,721

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F3 · price: This is the weighted average sales price representing 6,000 shares sold at prices ranging from $43.75 to $43.94 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
January 25, 2021 Filed Jan 27, 2021 21:17 UTC
Pellizzari Christine AChief Legal Officer
Exercise / conversionCommon Stock 6,000 $10.85 $65,100.00
Disclosure

SEC source: 0001104659-21-008179 · tm213966-2_4seq1.xml · nonDerivative · entry 3

Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,721

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
January 25, 2021 Filed Jan 27, 2021 21:17 UTC
Pellizzari Christine AChief Legal Officer
SaleCommon Stock 15,000 $42.95 $644,250.00
Disclosure

SEC source: 0001104659-21-008179 · tm213966-2_4seq1.xml · nonDerivative · entry 2

Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,721

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · price: This is the weighted average sales price representing 15,000 shares sold at prices ranging from $42.75 to $43.58 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
January 25, 2021 Filed Jan 27, 2021 21:17 UTC
Pellizzari Christine AChief Legal Officer
Exercise / conversionCommon Stock 15,000 $10.85 $162,750.00
Disclosure

SEC source: 0001104659-21-008179 · tm213966-2_4seq1.xml · nonDerivative · entry 1

Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 155,721

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
January 21, 2021 Filed Jan 22, 2021 21:49 UTC
Pellizzari Christine AChief Legal Officer
Exercise / conversionStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $10.85 $0.00
Disclosure

SEC source: 0001104659-21-006698 · tm213966-1_4seq1.xml · derivative · entry 9

Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,150

Underlying: Common Stock · 10,000 shares

Expires 2026-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
January 21, 2021 Filed Jan 22, 2021 21:49 UTC
Pellizzari Christine AChief Legal Officer
Exercise / conversionStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $10.85 $0.00
Disclosure

SEC source: 0001104659-21-006698 · tm213966-1_4seq1.xml · derivative · entry 8

Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,150

Underlying: Common Stock · 10,000 shares

Expires 2026-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
January 21, 2021 Filed Jan 22, 2021 21:49 UTC
Pellizzari Christine AChief Legal Officer
SaleCommon Stock 10,000 $41.98 $419,800.00
Disclosure

SEC source: 0001104659-21-006698 · tm213966-1_4seq1.xml · nonDerivative · entry 6

Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,721

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F4 · price: This is the weighted average sales price representing 10,000 shares sold at prices ranging from $41.75 to $42.19 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
January 21, 2021 Filed Jan 22, 2021 21:49 UTC
Pellizzari Christine AChief Legal Officer
Exercise / conversionCommon Stock 10,000 $10.85 $108,500.00
Disclosure

SEC source: 0001104659-21-006698 · tm213966-1_4seq1.xml · nonDerivative · entry 5

Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,721

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
January 21, 2021 Filed Jan 22, 2021 21:49 UTC
Pellizzari Christine AChief Legal Officer
SaleCommon Stock 10,000 $41.05 $410,500.00
Disclosure

SEC source: 0001104659-21-006698 · tm213966-1_4seq1.xml · nonDerivative · entry 4

Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,721

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F3 · price: This is the weighted average sales price representing 10,000 shares sold at prices ranging from $40.75 to $41.60 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
January 21, 2021 Filed Jan 22, 2021 21:49 UTC
Pellizzari Christine AChief Legal Officer
Exercise / conversionCommon Stock 10,000 $10.85 $108,500.00
Disclosure

SEC source: 0001104659-21-006698 · tm213966-1_4seq1.xml · nonDerivative · entry 3

Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,721

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
January 21, 2021 Filed May 14, 2021 20:18 UTC GiftCommon Stock 184 $0.00 $0.00
Disclosure

SEC source: 0001140361-21-017411 · form4.xml · nonDerivative · entry 5

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Melvin Sharoky C/F Sophie C. Wink UTMA/FL

Disclosed balance after: 184

F2 · kind: The reported transactions involved a gift of securities by the Reporting Person to an investment account, Melvin Sharoky C/F Sophie C. Wink UTMA/FL, for the benefit of the Reporting Person's granddaughter. The Reporting Person is the custodian of Melvin Sharoky C/F Sophie C. Wink UTMA/FL.

Read SEC document
January 21, 2021 Filed May 14, 2021 20:18 UTC GiftCommon Stock 184 $0.00 $0.00
Disclosure

SEC source: 0001140361-21-017411 · form4.xml · nonDerivative · entry 4

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 229,318

F2 · kind: The reported transactions involved a gift of securities by the Reporting Person to an investment account, Melvin Sharoky C/F Sophie C. Wink UTMA/FL, for the benefit of the Reporting Person's granddaughter. The Reporting Person is the custodian of Melvin Sharoky C/F Sophie C. Wink UTMA/FL.

Read SEC document
January 21, 2021 Filed May 14, 2021 20:18 UTC GiftCommon Stock 847 $0.00 $0.00
Disclosure

SEC source: 0001140361-21-017411 · form4.xml · nonDerivative · entry 3

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By spouse

Disclosed balance after: 847

F1 · kind: The reported transactions involved a gift of securities by the Reporting Person to his spouse.

Read SEC document
January 21, 2021 Filed May 14, 2021 20:18 UTC GiftCommon Stock 847 $0.00 $0.00
Disclosure

SEC source: 0001140361-21-017411 · form4.xml · nonDerivative · entry 2

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 229,502

F1 · kind: The reported transactions involved a gift of securities by the Reporting Person to his spouse.

Read SEC document
January 20, 2021 Filed Jan 22, 2021 21:49 UTC
Pellizzari Christine AChief Legal Officer
Exercise / conversionStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $10.85 $0.00
Disclosure

SEC source: 0001104659-21-006698 · tm213966-1_4seq1.xml · derivative · entry 7

Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,150

Underlying: Common Stock · 10,000 shares

Expires 2026-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
January 20, 2021 Filed Jan 22, 2021 21:49 UTC
Pellizzari Christine AChief Legal Officer
SaleCommon Stock 10,000 $39.87 $398,700.00
Disclosure

SEC source: 0001104659-21-006698 · tm213966-1_4seq1.xml · nonDerivative · entry 2

Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,721

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · price: This is the weighted average sales price representing 10,000 shares sold at prices ranging from $39.75 to $40.08 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
January 20, 2021 Filed Jan 22, 2021 21:49 UTC
Pellizzari Christine AChief Legal Officer
Exercise / conversionCommon Stock 10,000 $10.85 $108,500.00
Disclosure

SEC source: 0001104659-21-006698 · tm213966-1_4seq1.xml · nonDerivative · entry 1

Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,721

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
January 12, 2021 Filed May 14, 2021 20:18 UTC GiftCommon Stock 2,541 $0.00 $0.00
Disclosure

SEC source: 0001140361-21-017411 · form4.xml · nonDerivative · entry 1

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 230,349

Read SEC document
January 07, 2021 Filed Jan 8, 2021 21:40 UTC
Bonstein SaraChief Financial Officer
GrantStock Option (right to buy) · Derivative 45,600 $0.00 Strike: $34.03 $0.00
Disclosure

SEC source: 0001104659-21-002513 · tm211774-13_4seq1.xml · derivative · entry 2

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,600

Underlying: Common Stock · 45,600 shares

Expires 2031-01-07

F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
January 07, 2021 Filed Jan 8, 2021 21:40 UTC
Bonstein SaraChief Financial Officer
GrantCommon Stock 9,183 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-21-002513 · tm211774-13_4seq1.xml · nonDerivative · entry 1

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,183

F1 · shares: Restricted stock units granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant.

F2 · price: Each Restricted Stock Unit was received as a grant on January 7, 2021, for no consideration, and represents a contingent right to receive one share of Common Stock.

Read SEC document
January 07, 2021 Filed Jan 8, 2021 21:42 UTC
Flammer Martina M.D.Chief Medical Officer
GrantStock Option (right to buy) · Derivative 54,720 $0.00 Strike: $34.03 $0.00
Disclosure

SEC source: 0001104659-21-002514 · tm211774-14_4seq1.xml · derivative · entry 2

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,720

Underlying: Common Stock · 54,720 shares

Expires 2031-01-07

F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
January 07, 2021 Filed Jan 8, 2021 21:42 UTC
Flammer Martina M.D.Chief Medical Officer
GrantCommon Stock 11,019 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-21-002514 · tm211774-14_4seq1.xml · nonDerivative · entry 1

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,596

F1 · shares: Restricted stock units granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant.

F2 · price: Each Restricted Stock Unit was received as a grant on January 7, 2021, for no consideration, and represents a contingent right to receive one share of Common Stock.

Read SEC document
January 07, 2021 Filed Jan 8, 2021 21:40 UTC
Adsett RogerChief Commercial Officer
GrantStock Option (right to buy) · Derivative 54,720 $0.00 Strike: $34.03 $0.00
Disclosure

SEC source: 0001104659-21-002512 · tm211774-12_4seq1.xml · derivative · entry 2

Adsett Roger · CIK 0001685904 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,720

Underlying: Common Stock · 54,720 shares

Expires 2031-01-07

F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
January 07, 2021 Filed Jan 8, 2021 21:40 UTC
Adsett RogerChief Commercial Officer
GrantCommon Stock 11,019 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-21-002512 · tm211774-12_4seq1.xml · nonDerivative · entry 1

Adsett Roger · CIK 0001685904 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,552

F1 · shares: Restricted stock units granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant.

F2 · price: Each Restricted Stock Unit was received as a grant on January 7, 2021, for no consideration, and represents a contingent right to receive one share of Common Stock.

Read SEC document
January 07, 2021 Filed Jan 8, 2021 21:38 UTC
Pellizzari Christine AChief Legal Officer
GrantStock Option (right to buy) · Derivative 45,600 $0.00 Strike: $34.03 $0.00
Disclosure

SEC source: 0001104659-21-002508 · tm211774-10_4seq1.xml · derivative · entry 2

Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,600

Underlying: Common Stock · 45,600 shares

Expires 2031-01-07

F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
January 07, 2021 Filed Jan 8, 2021 21:38 UTC
Pellizzari Christine AChief Legal Officer
GrantCommon Stock 9,183 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-21-002508 · tm211774-10_4seq1.xml · nonDerivative · entry 1

Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,721

F1 · shares: Restricted stock units granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant.

F2 · price: Each Restricted Stock Unit was received as a grant on January 7, 2021, for no consideration, and represents a contingent right to receive one share of Common Stock.

Read SEC document
January 07, 2021 Filed Jan 8, 2021 21:39 UTC
Lewis WilliamDirector · Chair & CEO
GrantStock Option (right to buy) · Derivative 109,440 $0.00 Strike: $34.03 $0.00
Disclosure

SEC source: 0001104659-21-002510 · tm211774-11_4seq1.xml · derivative · entry 2

Lewis William · CIK 0001402051 · Director · Chair & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,440

Underlying: Common Stock · 109,440 shares

Expires 2031-01-07

F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
January 07, 2021 Filed Jan 8, 2021 21:39 UTC
Lewis WilliamDirector · Chair & CEO
GrantCommon Stock 22,039 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-21-002510 · tm211774-11_4seq1.xml · nonDerivative · entry 1

Lewis William · CIK 0001402051 · Director · Chair & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 179,608

F1 · shares: Restricted stock units granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant.

F2 · price: Each Restricted Stock Unit was received as a grant on January 7, 2021, for no consideration, and represents a contingent right to receive one share of Common Stock.

Read SEC document
January 07, 2021 Filed Jan 8, 2021 21:38 UTC
Schaeffer Orlov S NicoleChief People Strategy Officer
GrantStock Option (right to buy) · Derivative 36,480 $0.00 Strike: $34.03 $0.00
Disclosure

SEC source: 0001104659-21-002506 · tm211774-9_4seq1.xml · derivative · entry 2

Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,480

Underlying: Common Stock · 36,480 shares

Expires 2031-01-07

F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
January 07, 2021 Filed Jan 8, 2021 21:38 UTC
Schaeffer Orlov S NicoleChief People Strategy Officer
GrantCommon Stock 7,346 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-21-002506 · tm211774-9_4seq1.xml · nonDerivative · entry 1

Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,920

F1 · shares: Restricted stock units granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant.

F2 · price: Each Restricted Stock Unit was received as a grant on January 7, 2021, for no consideration, and represents a contingent right to receive one share of Common Stock.

Read SEC document
January 07, 2021 Filed Jan 8, 2021 21:37 UTC
SORIANO JOHNChief Compliance Officer
GrantStock Option (right to buy) · Derivative 27,360 $0.00 Strike: $34.03 $0.00
Disclosure

SEC source: 0001104659-21-002505 · tm211774-8_4seq1.xml · derivative · entry 2

SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,360

Underlying: Common Stock · 27,360 shares

Expires 2031-01-07

F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
January 07, 2021 Filed Jan 8, 2021 21:37 UTC
SORIANO JOHNChief Compliance Officer
GrantCommon Stock 5,509 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-21-002505 · tm211774-8_4seq1.xml · nonDerivative · entry 1

SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,773

F1 · shares: Restricted stock units granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant.

F2 · price: Each Restricted Stock Unit was received as a grant on January 7, 2021, for no consideration, and represents a contingent right to receive one share of Common Stock.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 22:14 UTC
Lewis WilliamChair & CEO
Tax withholdingCommon Stock 2,963 $33.42 $99,023.46
Disclosure

SEC source: 0001104659-21-001607 · tm211774d6_4.xml · nonDerivative · entry 2

Lewis William · CIK 0001402051 · Chair & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 157,569

F1 · shares: Shares withheld by the Company to satisfy tax withholding requirements on vesting of time-based restricted stock units.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 22:13 UTC
Adsett RogerChief Commercial Officer
Tax withholdingCommon Stock 1,223 $33.42 $40,872.66
Disclosure

SEC source: 0001104659-21-001605 · tm211774d4_4seq1.xml · nonDerivative · entry 3

Adsett Roger · CIK 0001685904 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,533

F2 · shares: Shares withheld by the Company to satisfy tax withholding requirements on vesting of time-based restricted stock units.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 22:12 UTC
Pellizzari Christine AChief Legal Officer
Tax withholdingCommon Stock 650 $33.42 $21,723.00
Disclosure

SEC source: 0001104659-21-001604 · tm211774d3_4seq1.xml · nonDerivative · entry 2

Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,538

F1 · shares: Shares withheld by the Company to satisfy tax withholding requirements on vesting of time-based restricted stock units.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 22:12 UTC
Schaeffer Orlov S NicoleChief People Strategy Officer
Tax withholdingCommon Stock 910 $33.42 $30,412.20
Disclosure

SEC source: 0001104659-21-001602 · tm211774-2_4seq1.xml · nonDerivative · entry 2

Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,574

F1 · shares: Shares withheld by the Company to satisfy tax withholding requirements on vesting of time-based restricted stock units.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 22:11 UTC
Lewis WilliamDirector · Chair & CEO
OtherStock Option (right to buy) · Derivative 245,950 $0.00 Strike: $10.85 $0.00
Disclosure

SEC source: 0001104659-21-001601 · tm211774-1_4seq1.xml · derivative · entry 29

Lewis William · CIK 0001402051 · Director · Chair & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By spouse

Disclosed balance after: 0

Underlying: Common Stock · 245,950 shares

Expires 2026-05-19

F6 · kind: The reported transactions involve transfers of options from the reporting person's spouse to a family trust, ARTICLE 4 TRUST UNDER KATIE PROCTER DYNASTY TRUST, of which the reporting person is a trustee. The reporting person and members of the reporting person's immediate family are the sole beneficiaries of the trust.

F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.